Racial disparities in intravenous recombinant tissue plasminogen activator use persist at primary stroke centers

Journal of the American Heart Association

Volumn 4, Issue 10, 2015, Pages

  Aparicio, Hugo J ^a,b   Carr, Brendan G ^c   Kasner, Scott E ^b   Kallan, Michael J ^b   Albright, Karen C ^d,e   Kleindorfer, Dawn O ^f   Mullen, Michael T ^b  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^e UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^f UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Health disparities; Health policy; Stroke; Stroke care; Thrombolysis

Indexed keywords

ALTEPLASE; FIBRINOLYTIC AGENT; RECOMBINANT PROTEIN; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; AGE DISTRIBUTION; AGED; AMERICAN INDIAN; ARTICLE; ASIAN; BLACK PERSON; BRAIN ISCHEMIA; CAUCASIAN; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HEALTH INSURANCE; HISPANIC; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PACIFIC ISLANDER; PRIORITY JOURNAL; RACE DIFFERENCE; RETROSPECTIVE STUDY; SEX DIFFERENCE; TREATMENT OUTCOME; ADOLESCENT; AFRICAN AMERICAN; CHI SQUARE DISTRIBUTION; COMPARATIVE STUDY; EPIDEMIOLOGY; ETHNOLOGY; FACTUAL DATABASE; FIBRINOLYTIC THERAPY; HEALTH CARE DELIVERY; HEALTH CARE DISPARITY; HEALTH CARE POLICY; INTRAVENOUS DRUG ADMINISTRATION; MULTIVARIATE ANALYSIS; ODDS RATIO; RISK FACTOR; SOCIOECONOMICS; STROKE; UNITED STATES; UTILIZATION; YOUNG ADULT;

ADMINISTRATION, INTRAVENOUS; ADOLESCENT; ADULT; AFRICAN AMERICANS; AGED; CHI-SQUARE DISTRIBUTION; DATABASES, FACTUAL; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FIBRINOLYTIC AGENTS; HEALTH POLICY; HEALTH SERVICES ACCESSIBILITY; HEALTHCARE DISPARITIES; HISPANIC AMERICANS; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; RECOMBINANT PROTEINS; RETROSPECTIVE STUDIES; RISK FACTORS; SOCIOECONOMIC FACTORS; STROKE; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME; UNITED STATES; YOUNG ADULT;

EID: 85006216179     PISSN: None     EISSN: 20479980     Source Type: Journal    
DOI: 10.1161/JAHA.115.001877     Document Type: Article

References (65)

1. Marler JR, Tilley BC, Lu M, Brott TG, Lyden PC, Grotta JC, Broderick JP, Levine SR, Frankel MP, Horowitz SH, Haley EC, Lewandowski CA, Kwiatkowski TP. Early stroke treatment associated with better outcome: the NINDS rt-PA Stroke Study. Neurology. 2000;55:1649-1655.
2. Del Zoppo GJ, Saver JL, Jauch EC, Adams HP; Council AHAS. Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator: a science advisory from the American Heart Association/American Stroke Association. Stroke. 2009;40:2945-2948.
3. Physicians ACoE, Neurology AAo. Clinical policy: use of intravenous tPA for the management of acute ischemic stroke in the emergency department. Ann Emerg Med. 2013;61:225-243.
4. Schwamm LH, Ali SF, Reeves MJ, Smith EE, Saver JL, Messe S, Bhatt DL, Grau-Sepulveda MV, Peterson ED, Fonarow GC. Temporal trends in patient characteristics and treatment with intravenous thrombolysis among acute ischemic stroke patients at Get With The Guidelines-Stroke hospitals. Circ Cardiovasc Qual Outcomes. 2013;6:543-549.
5. Investigators CASPRC. Prioritizing interventions to improve rates of thrombolysis for ischemic stroke. Neurology. 2005;64:654-659.
6. Barber PA, Zhang J, Demchuk AM, Hill MD, Buchan AM. Why are stroke patients excluded from tPA therapy? An analysis of patient eligibility Neurology. 2001;56:1015-1020.
7. Willey JZ, Petersen N, Dhamoon MS, Stillman J, Boden-Albala B, Elkind MS, Marshall RS. Safety of thrombolysis in patients over the age of 80. Neurologist. 2012;18:99-101.
8. Johnston SC, Fung LH, Gillum LA, Smith WS, Brass LM, Lichtman JH, Brown AN. Utilization of intravenous tissue-type plasminogen activator for ischemic stroke at academic medical centers: the influence of ethnicity. Stroke. 2001;32:1061-1068.
9. Kimball MM, Neal D, Waters MF, Hoh BL. Race and income disparity in ischemic stroke care: Nationwide Inpatient Sample database, 2002 to 2008. J Stroke Cerebrovasc Dis. 2012;23:17-24.
10. Rost NS, Smith EE, Pervez MA, Mello P, Dreyer P, Schwamm LH. Predictors of increased intravenous tissue plasminogen activator use among hospitals participating in the Massachusetts Primary Stroke Service program. Circ Cardiovasc Qual Outcomes. 2012;5:314-320.
11. Mullen MT, Judd S, Howard VJ, Kasner SE, Branas CC, Albright KC, Rhodes JD, Kleindorfer DO, Carr BG. Disparities in evaluation at certified primary stroke centers: reasons for geographic and racial differences in stroke. Stroke. 2013;44:1930-1935.
12. Ekundayo OJ, Saver JL, Fonarow GC, Schwamm LH, Xian Y, Zhao X, Hernandez AF, Peterson ED, Cheng EM. Patterns of emergency medical services use and its association with timely stroke treatment: findings from Get With The Guidelines-Stroke. Circ Cardiovasc Qual Outcomes. 2013;6:262-269.
13. Alberts MJ, Latchaw RE, Jagoda A, Wechsler LR, Crocco T, George MG, Connolly ES, Mancini B, Prudhomme S, Gress D, Jensen ME, Bass R, RuffR, Foell K, Armonda RA, Emr M, Warren M, Baranski J, Walker MD; Coalition BA. Revised and updated recommendations for the establishment of primary stroke centers: a summary statement from the Brain Attack Coalition. Stroke. 2011;42:2651-2665.
14. Facts about primary stroke center certification. The Joint Commission website. 2015 Available at: http://www.jointcommission.org/facts_about_primary_stroke_center_certification/. Accessed January 30, 2015.
15. Song S, Saver J. Growth of regional acute stroke systems of care in the United States in the first decade of the 21st century. Stroke. 2012;43:1975-1978.
16. Prabhakaran S, McNulty M, O'Neill K, Ouyang B. Intravenous thrombolysis for stroke increases over time at primary stroke centers. Stroke. 2012;43:875-877.
17. Mullen MT, Kasner SE, Kallan MJ, Kleindorfer DO, Albright KC, Carr BG. Joint Commission primary stroke centers utilize more rt-PA in the Nationwide Inpatient Sample. J Am Heart Assoc. 2013;2:e000071 doi: 10.1161/JAHA.112.000071.
18. Xian Y, Holloway RG, Chan PS, Noyes K, Shah MN, Ting HH, Chappel AR, Peterson ED, Friedman B. Association between stroke center hospitalization for acute ischemic stroke and mortality. JAMA. 2011;305:373-380.
19. Lichtman JH, Jones SB, Wang Y, Watanabe E, Leifheit-Limson E, Goldstein LB. Outcomes after ischemic stroke for hospitals with and without Joint Commission-certified primary stroke centers. Neurology. 2011;76:1976-1982.
20. Kleindorfer D, de los Rios La Rosa F, Khatri P, Kissela B, Mackey J, Adeoye O. Temporal trends in acute stroke management. Stroke. 2013;44:S129-S131.
21. Reed SD, Cramer SC, Blough DK, Meyer K, Jarvik JG. Treatment with tissue plasminogen activator and inpatient mortality rates for patients with ischemic stroke treated in community hospitals. Stroke. 2001;32:1832-1840.
22. Hsia AW, Edwards DF, Morgenstern LB, Wing JJ, Brown NC, Coles R, Loftin S, Wein A, Koslosky SS, Fatima S, Sanchez BN, Fokar A, Gibbons MC, Shara N, Jayam-Trouth A, Kidwell CS. Racial disparities in tissue plasminogen activator treatment rate for stroke: a population-based study. Stroke. 2011;42:2217-2221.
23. Schumacher HC, Bateman BT, Boden-Albala B, Berman MF, Mohr JP, Sacco RL, Pile-Spellman J. Use of thrombolysis in acute ischemic stroke: analysis of the Nationwide Inpatient Sample 1999 to 2004. Ann Emerg Med. 2007;50:99-107.
24. Nasr DM, Brinjikji W, Cloft HJ, Rabinstein AA. Racial and ethnic disparities in the use of intravenous recombinant tissue plasminogen activator and outcomes for acute ischemic stroke. J Stroke Cerebrovasc Dis. 2013;22:154-160.
25. Goldstein LB, Matchar DB, Hoff-Lindquist J, Samsa GP, Horner RD. Veterans Administration Acute Stroke (VAST) study: lack of race/ethnic-based differences in utilization of stroke-related procedures or services. Stroke. 2003;34:999-1004.
26. Siegler JE, Boehme AK, Albright KC, Martin-Schild S. Ethnic disparities trump other risk factors in determining delay to emergency department arrival in acute ischemic stroke. Ethn Dis. 2013;23:29-34.
27. Schwamm LH, Reeves MJ, Pan W, Smith EE, Frankel MR, Olson D, Zhao X, Peterson E, Fonarow GC. Race/ethnicity, quality of care, and outcomes in ischemic stroke. Circulation. 2010;121:1492-1501.
28. Cruz-Flores S, Rabinstein A, Biller J, Elkind MS, Griffith P, Gorelick PB, Howard G, Leira EC, Morgenstern LB, Ovbiagele B, Peterson E, Rosamond W, Trimble B, Valderrama AL; Council AHAS, Nursing CoC, Prevention CoEa, Research CoQoCaO. Racial-ethnic disparities in stroke care: the American experience: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011;42:2091-2116.
29. Overview of the National (Nationwide) Inpatient Sample (NIS). Healthcare cost and utilization project website. 2015. Available at: http://www.hcup-us.ahrq.-gov/nisoverview.jsp. Accessed January 30, 2015.
30. Andrade SH, Tjia J, Cutrona S, Saczynski J, Goldberg R, Gurwitz J. Mini-sentinel systematic evaluation of health outcome of interest definitions for studies using administrative data: cerebrovascular/transient ischemic attack report. 2011.
31. Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care. 1998;36:8-27.
32. Averill RF, Goldfield NI, Muldoon J, Steinbeck BA, Grant TM. A closer look at allpatient refined DRGs. J AHIMA. 2002;73:46-50.
33. U.S. Census Bureau projections show a slower growing, older, more diverse nation a half century from now. United States Census Bureau website. 2012. Available at: https://www.census.gov/newsroom/releases/archives/population/cb12-243.html. Accessed January 30, 2015.
34. Ovbiagele B, Goldstein LB, Higashida RT, Howard VJ, Johnston SC, Khavjou OA, Lackland DT, Lichtman JH, Mohl S, Sacco RL, Saver JL, Trogdon JG; Council AHAACCaS. Forecasting the future of stroke in the United States: a policy statement from the American Heart Association and American Stroke Association. Stroke. 2013;44:2361-2375.
35. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Blaha MJ, Dai S, Ford ES, Fox CS, Franco S, Fullerton HJ, Gillespie C, Hailpern SM, Heit JA, Howard VJ, Huffman MD, Judd SE, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Mackey RH, Magid DJ, Marcus GM, Marelli A, Matchar DB, McGuire DK, Mohler ER, Moy CS, Mussolino ME, Neumar RW, Nichol G, Pandey DK, Paynter NP, Reeves MJ, Sorlie PD, Stein J, Towfighi A, Turan TN, Virani SS, Wong ND, Woo D, Turner MB; on behalf of the AHA SCaSS subcommittee. Heart disease and stroke statistics-2014 update: a report from the American Heart Association. Circulation. 2014;129:e28-292.
36. Howard VJ. Reasons underlying racial differences in stroke incidence and mortality. Stroke. 2013;44:S126-S128.
37. Morgenstern LB, Smith MA, Sanchez BN, Brown DL, Zahuranec DB, Garcia N, Kerber KA, Skolarus LE, Meurer WJ, Burke JF, Adelman EE, Baek J, Lisabeth LD. Persistent ischemic stroke disparities despite declining incidence in Mexican Americans. Ann Neurol. 2013;74:778-785.
38. Kleindorfer DO, Khoury J, Moomaw CJ, Alwell K, Woo D, Flaherty ML, Khatri P, Adeoye O, Ferioli S, Broderick JP, Kissela BM. Stroke incidence is decreasing in whites but not in blacks: a population-based estimate of temporal trends in stroke incidence from the Greater Cincinnati/Northern Kentucky Stroke Study. Stroke. 2010;41:1326-1331.
39. Stansbury JP, Jia H, Williams LS, Vogel WB, Duncan PW. Ethnic disparities in stroke: epidemiology, acute care, and postacute outcomes. Stroke. 2005;36:374-386.
40. Bhattacharya P, Mada F, Salowich-Palm L, Hinton S, Millis S, Watson SR, Chaturvedi S, Rajamani K. Are racial disparities in stroke care still prevalent in certified stroke centers? J Stroke Cerebrovasc Dis. 2013;22:383-388.
41. Berk ML, Schur CL. The effect of fear on access to care among undocumented Latino immigrants. J Immigr Health. 2001;3:151-156.
42. Mullen MT, Wiebe DJ, Bowman A, WolffCS, Albright KC, Roy J, Balcer LJ, Branas CC, Carr BG. Disparities in accessibility of certified primary stroke centers. Stroke. 2014;45:3381-3388.
43. McDonald CM, Cen S, Ramirez L, Song S, Saver JL, Mack WJ, Sanossian N. Hospital and demographic characteristics associated with advanced primary stroke center designation. Stroke. 2014;45:3717-3719.
44. Trimble B, Morgenstern LB. Stroke in minorities. Neurol Clin. 2008;26:1177-1190.
45. Fonarow GC, Reeves MJ, Zhao X, Olson DM, Smith EE, Saver JL, Schwamm LH; Investigators GWtG-SSCa. Age-related differences in characteristics, performance measures, treatment trends, and outcomes in patients with ischemic stroke. Circulation. 2010;121:879-891.
46. Toni D, Ahmed N, Anzini A, Lorenzano S, Brozman M, Kaste M, Mikulik R, Putaala J, Wahlgren N; Investigators S. Intravenous thrombolysis in young stroke patients: results from the SITS-ISTR. Neurology. 2012;78: 880-887.
47. Nedeltchev K, der Maur TA, Georgiadis D, Arnold M, Caso V, Mattle HP, Schroth G, Remonda L, Sturzenegger M, Fischer U, Baumgartner RW. Ischaemic stroke in young adults: predictors of outcome and recurrence. J Neurol Neurosurg Psychiatry. 2005;76:191-195.
48. Tsivgoulis G, Putaala J, Sharma VK, Balucani C, Martin-Schild S, Giannopoulos S, Batala L, Krogias C, Palazzo P, Shahripour RB, Arvaniti C, Barlinn K, Strbian D, Haapaniemi E, Flamouridou M, Vadikolias K, Heliopoulos I, Voumvourakis K, Triantafyllou N, Azarpazhooh MR, Athanasiadis D, Kosmidou M, Katsanos AH, Vasdekis SN, Stefanis L, Stamboulis E, Piperidou C, Tatlisumak T, Alexandrov AV. Racial disparities in early mortality in 1,134 young patients with acute stroke. Neurol Sci. 2014;35:1041-1049.
49. Lisabeth LD, Sanchez BN, Baek J, Skolarus LE, Smith MA, Garcia N, Brown DL, Morgenstern LB. Neurological, functional, and cognitive stroke outcomes in Mexican Americans. Stroke. 2014;45:1096-1101.
50. Moser DK, Kimble LP, Alberts MJ, Alonzo A, Croft JB, Dracup K, Evenson KR, Go AS, Hand MM, Kothari RU, Mensah GA, Morris DL, Pancioli AM, Riegel B, Zerwic JJ. Reducing delay in seeking treatment by patients with acute coronary syndrome and stroke: a scientific statement from the American Heart Association Council on Cardiovascular Nursing and Stroke Council. Circulation. 2006;114:168-182.
51. Rossnagel K, Jungehulsing GJ, Nolte CH, Muller-Nordhorn J, Roll S, Wegscheider K, Villringer A, Willich SN. Out-of-hospital delays in patients with acute stroke. Ann Emerg Med. 2004;44:476-483.
52. Lacy CR, Suh DC, Bueno M, Kostis JB. Delay in presentation and evaluation for acute stroke: stroke Time Registry for Outcomes Knowledge and Epidemiology (S.T.R.O.K.E.). Stroke. 2001;32:63-69.
53. Morris DL, Rosamond W, Madden K, Schultz C, Hamilton S. Prehospital and emergency department delays after acute stroke: the Genentech Stroke Presentation Survey. Stroke. 2000;31:2585-2590.
54. Tuhrim S, Godbold JH, Goldman ME, Horowitz DR, Weinberger J. The Minorities Risk Factors and stroke Study (MRFASS). Design, methods and baseline characteristics. Neuroepidemiology. 1997;16:224-233.
55. Smith MA, Doliszny KM, Shahar E, McGovern PG, Arnett DK, Luepker RV. Delayed hospital arrival for acute stroke: the Minnesota Stroke Survey. Ann Intern Med. 1998;129:190-196.
56. Menon SC, Pandey DK, Morgenstern LB. Critical factors determining access to acute stroke care. Neurology. 1998;51:427-432.
57. Goldstein LB, Edwards MG, Wood DP. Delay between stroke onset and emergency department evaluation. Neuroepidemiology. 2001;20:196-200.
58. Kothari R, Jauch E, Broderick J, Brott T, Sauerbeck L, Khoury J, Liu T. Acute stroke: delays to presentation and emergency department evaluation. Ann Emerg Med. 1999;33:3-8.
59. Boehme AK, Siegler JE, Mullen MT, Albright KC, Lyerly MJ, Monlezun DJ, Jones EM, Tanner R, Gonzales NR, Beasley TM, Grotta JC, Savitz SI, Martin-Schild S. Racial and gender differences in stroke severity, outcomes, and treatment in patients with acute ischemic stroke. J Stroke Cerebrovasc Dis. 2014;23:e255-e261.
60. Adeoye O, Lindsell C, Broderick J, Alwell K, Jauch E, Moomaw CJ, Flaherty ML, Pancioli A, Kissela B, Kleindorfer D. Emergency medical services use by stroke patients: a population-based study. Am J Emerg Med. 2009;27:141-145.
61. Ennis SR, Rios-Vargas M, Albert NG. The Hispanic Population: 2010. United States Census Bureau website. 2011. Available at: http://www.census.gov/prod/cen2010/briefs/c2010br-04.pdf. Accessed January 30, 2015.
62. Rastogi S, Johnson TD, Hoeffel EM, Drewery J, Malcolm P. The Black Population: 2010. United States Census Bureau website. 2011. Available at: http://www.census.gov/prod/cen2010/briefs/c2010br-06.pdf. Accessed January 30, 2015.
63. Kleindorfer D, Lindsell CJ, Brass L, Koroshetz W, Broderick JP. National US estimates of recombinant tissue plasminogen activator use: ICD-9 codes substantially underestimate. Stroke. 2008;39:924-928.
64. Adeoye O, Hornung R, Khatri P, Kleindorfer D. Recombinant tissue-type plasminogen activator use for ischemic stroke in the United States: a doubling of treatment rates over the course of 5 years. Stroke. 2011;42:1952-1955.
65. Qureshi AI, Harris-Lane P, Siddiqi F, Kirmani JF. International Classification of Diseases and Current Procedural Terminology codes underestimated thrombolytic use for ischemic stroke. J Clin Epidemiol. 2006;59:856-858.